177 related articles for article (PubMed ID: 14706261)
21. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
Dave VS; Fahmy RM; Bensley D; Hoag SW
Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
[TBL] [Abstract][Full Text] [Related]
22. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
23. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
Kidokoro M; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2001; 6(2):263-75. PubMed ID: 11417001
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
[TBL] [Abstract][Full Text] [Related]
25. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion.
Lyons JG; Devine DM; Kennedy JE; Geever LM; O'Sullivan P; Higginbotham CL
Eur J Pharm Biopharm; 2006 Aug; 64(1):75-81. PubMed ID: 16697170
[TBL] [Abstract][Full Text] [Related]
26. Release behaviour of clozapine matrix pellets based on percolation theory.
Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
[TBL] [Abstract][Full Text] [Related]
27. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics.
Bonny JD; Leuenberger H
Pharm Acta Helv; 1991; 66(5-6):160-4. PubMed ID: 1784581
[TBL] [Abstract][Full Text] [Related]
28. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
29. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical applications of hot-melt extrusion: part I.
Crowley MM; Zhang F; Repka MA; Thumma S; Upadhye SB; Battu SK; McGinity JW; Martin C
Drug Dev Ind Pharm; 2007 Sep; 33(9):909-26. PubMed ID: 17891577
[TBL] [Abstract][Full Text] [Related]
31. Roller compaction of different pseudopolymorphic forms of theophylline: Effect on compressibility and tablet properties.
Hadzović E; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Aug; 396(1-2):53-62. PubMed ID: 20600735
[TBL] [Abstract][Full Text] [Related]
32. Properties of sustained-release tablets prepared by hot-melt extrusion.
Zhang F; McGinity JW
Pharm Dev Technol; 1999 May; 4(2):241-50. PubMed ID: 10231885
[TBL] [Abstract][Full Text] [Related]
33. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
Fukuda M; Peppas NA; McGinity JW
Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
[TBL] [Abstract][Full Text] [Related]
34. Surelease or organic solution of ethylcellulose in preparation of sustained release theophylline micromatrices or matrices using spray drying technique.
Afrasiabi Garekani H; Sedighi S; Sadeghi F
Pharm Dev Technol; 2015 Mar; 20(2):204-10. PubMed ID: 24286215
[TBL] [Abstract][Full Text] [Related]
35. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.
Agrawal AM; Neau SH; Bonate PL
AAPS PharmSci; 2003; 5(2):E13. PubMed ID: 12866940
[TBL] [Abstract][Full Text] [Related]
36. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
37. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
Fukuda M; Peppas NA; McGinity JW
J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
[TBL] [Abstract][Full Text] [Related]
38. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
39. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
[TBL] [Abstract][Full Text] [Related]
40. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
